The Wider Public Health Value of HCV Treatment Accrued by Liver Transplant Recipients
May 3rd 2016Advances in treatment for hepatitis C virus (HCV) have the potential to generate considerable spillover benefits to patients awaiting transplants, especially among those with non—HCV-mediated liver failure.
A Way Out of the Dismal Arithmetic of Hepatitis C Treatment
May 3rd 2016This special issue presents important new peer-reviewed research, covering issues ranging from access and the out-of-pocket costs of a treatment course, to the real-world consequences-both economic and clinical-of failing to treat.